{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:06:25Z","timestamp":1792317985861,"version":"4.4.0"},"reference-count":50,"publisher":"Portland Press Ltd.","issue":"10","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Podocyte damage and loss are the early event in the development of focal segmental glomerulosclerosis (FSGS). Podocytes express angiotensin II type-2-receptor (AT2R), which may play a key role in maintaining kidney integrity and function. Here, we examined the effects of AT2R deletion and AT2R agonist compound 21 (C21) on the evolution of FSGS. FSGS was induced by adriamycin (ADR) injection in both male wild-type (WT) and AT2R knockout (KO) mice. C21 was administered to WT-FSGS mice either one day before or 7 days after ADR (Pre-C21 or Post-C21), using two doses of C21 at either 0.3 (low dose, LD) or 1.0 (high dose, HD) mg\/kg\/day. ADR-induced FSGS was more severe in AT2RKO mice compared with WT-FSGS mice, and included profound podocyte loss, glomerular fibrosis, and albuminuria. Glomerular cathepsin L expression increased more in AT2RKO-FSGS than in WT-FSGS mice. C21 treatment ameliorated podocyte injury, most significantly in the Pre C21-HD group, and inhibited glomerular cathepsin L expression. In vitro, Agtr2 knock-down in mouse podocyte cell line given ADR confirmed the in vivo data. Mechanistically, C21 inhibited cathepsin L expression, which protected synaptopodin from destruction and stabilized actin cytoskeleton. C21 also prevented podocyte apoptosis. In conclusion, AT2R activation by C21 ameliorated ADR-induced podocyte injury in mice by the inhibition of glomerular cathepsin L leading to the maintenance of podocyte integrity and prevention of podocyte apoptosis.<\/jats:p>","DOI":"10.1042\/cs20220188","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T10:25:51Z","timestamp":1651573551000},"page":"715-731","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice"],"prefix":"10.1042","volume":"136","author":[{"given":"Min-Chun","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-4666","authenticated-orcid":false,"given":"Kana\u00a0N.","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"},{"name":"Division of Nephrology, Department of Internal Medicine, Saint Louis University, 1008 Spring Ave. St Louis, MO 63110, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiao-Ying","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ping","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-7987","authenticated-orcid":false,"given":"Chao-Sheng","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad-Ali","family":"El-Mortada","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzheng","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Chenier","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michifumi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie\u00a0R.","family":"Ingelfinger","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology Unit, Mass General Hospital for Children at Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-454X","authenticated-orcid":false,"given":"John\u00a0S.D.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-6970","authenticated-orcid":false,"given":"Shao-Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), 900 Saint Denis Street, Montr\u00e9al, QC, Canada H2X 0A9"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"2022052008350495400_B1","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D'Agati","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2022052008350495400_B2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0272-6386(04)01081-9","article-title":"Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States","volume":"44","author":"Kitiyakara","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"2022052008350495400_B3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2022052008350495400_B4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"2022052008350495400_B5","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","article-title":"The podocyte's response to injury: role in proteinuria and glomerulosclerosis","volume":"69","author":"Shankland","year":"2006","journal-title":"Kidney Int."},{"key":"2022052008350495400_B6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.ackd.2014.01.010","article-title":"Treatment of FSGS in Children","volume":"21","author":"Sethna","year":"2014","journal-title":"Adv. Chronic Kidney Dis."},{"key":"2022052008350495400_B7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCRESAHA.116.308384","article-title":"AT2 receptor activation prevents sodium retention and reduces blood pressure in angiotensin II-dependent hypertension","volume":"119","author":"Kemp","year":"2016","journal-title":"Circ. Res."},{"key":"2022052008350495400_B8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","article-title":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats","volume":"59","author":"Rehman","year":"2012","journal-title":"Hypertension"},{"key":"2022052008350495400_B9","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00125-021-05483-7","article-title":"AT(2)R deficiency in mice accelerates podocyte dysfunction in diabetic progeny in a sex-dependent manner","volume":"64","author":"Liao","year":"2021","journal-title":"Diabetologia"},{"key":"2022052008350495400_B10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/path.4946","article-title":"AT2 R deficiency mediated podocyte loss via activation of ectopic hedgehog interacting protein (Hhip) gene expression","volume":"243","author":"Liao","year":"2017","journal-title":"J. Pathol."},{"key":"2022052008350495400_B11","doi-asserted-by":"publisher","first-page":"F710","DOI":"10.1152\/ajprenal.00475.2004","article-title":"Functional expression of the renin-angiotensin system in human podocytes","volume":"290","author":"Liebau","year":"2006","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"2022052008350495400_B12","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.2353\/ajpath.2007.060484","article-title":"Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall","volume":"170","author":"Suzuki","year":"2007","journal-title":"Am. J. Pathol."},{"key":"2022052008350495400_B13","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00467-007-0505-3","article-title":"Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS","volume":"22","author":"Copelovitch","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"2022052008350495400_B14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1046\/j.1365-2796.2003.01071.x","article-title":"Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment","volume":"253","author":"Usta","year":"2003","journal-title":"J. Intern. Med."},{"key":"2022052008350495400_B15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/ki.2015.178","article-title":"Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria","volume":"88","author":"Hayashi","year":"2015","journal-title":"Kidney Int."},{"key":"2022052008350495400_B16","doi-asserted-by":"publisher","first-page":"F173","DOI":"10.1152\/ajprenal.00240.2001","article-title":"Angiotensin II induces apoptosis in rat glomerular epithelial cells","volume":"283","author":"Ding","year":"2002","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"2022052008350495400_B17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1523-1755.2004.00362.x","article-title":"Activation of a local tissue angiotensin system in podocytes by mechanical strain","volume":"65","author":"Durvasula","year":"2004","journal-title":"Kidney Int."},{"key":"2022052008350495400_B18","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/ndt\/gfh837","article-title":"Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy","volume":"20","author":"Chen","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"2022052008350495400_B19","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","article-title":"Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?","volume":"118","author":"Kaschina","year":"2008","journal-title":"Circulation"},{"key":"2022052008350495400_B20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/HYPERTENSIONAHA.110.164202","article-title":"Angiotensin AT(2) receptor stimulation inhibits early renal inflammation in renovascular hypertension","volume":"57","author":"Matavelli","year":"2011","journal-title":"Hypertension"},{"key":"2022052008350495400_B21","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.120.11941","article-title":"Angiotensin II Type 2 receptor: a target for protection against hypertension, metabolic dysfunction, and organ remodeling","volume":"77","author":"Fatima","year":"2021","journal-title":"Hypertension"},{"key":"2022052008350495400_B22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/01.HYP.0000151622.47814.6f","article-title":"Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis\/diuresis in obese Zucker rats","volume":"45","author":"Hakam","year":"2005","journal-title":"Hypertension"},{"key":"2022052008350495400_B23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1161\/HYPERTENSIONAHA.111.00422","article-title":"Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats","volume":"61","author":"Dhande","year":"2013","journal-title":"Hypertension"},{"key":"2022052008350495400_B24","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1046\/j.1523-1755.64.s86.5.x","article-title":"Renal expression of angiotensin type 2 (AT2) receptors during kidney damage","author":"Ruiz-Ortega","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"2022052008350495400_B25","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1161\/HYPERTENSIONAHA.115.06881","article-title":"Angiotensin II type 2-receptor agonist C21 reduces proteinuria and oxidative stress in kidney of high-salt-fed obese Zucker Rats","volume":"67","author":"Patel","year":"2016","journal-title":"Hypertension"},{"key":"2022052008350495400_B26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrology (Carlton)."},{"key":"2022052008350495400_B27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1369\/0022155418791822","article-title":"Expression of Cathepsin L and its intrinsic inhibitors in glomeruli of rats with puromycin aminonucleoside nephrosis","volume":"66","author":"Kubo","year":"2018","journal-title":"J. Histochem. Cytochem."},{"key":"2022052008350495400_B28","doi-asserted-by":"publisher","first-page":"109718","DOI":"10.1016\/j.mehy.2020.109718","article-title":"Role of cathepsin L in idiopathic nephrotic syndrome in children","volume":"141","author":"Keisuke","year":"2020","journal-title":"Med. Hypotheses"},{"key":"2022052008350495400_B29","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/377748a0","article-title":"Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor","volume":"377","author":"Ichiki","year":"1995","journal-title":"Nature"},{"key":"2022052008350495400_B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1097-2765(00)80169-0","article-title":"Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men","volume":"3","author":"Nishimura","year":"1999","journal-title":"Mol. Cell."},{"key":"2022052008350495400_B31","doi-asserted-by":"publisher","first-page":"521076","DOI":"10.1155\/2011\/521076","article-title":"Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2","volume":"2011","author":"Chang","year":"2011","journal-title":"Exp. Diab. Res."},{"key":"2022052008350495400_B32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1159\/000169057","article-title":"Sex difference in progression of adriamycin-induced nephropathy in rats","volume":"16","author":"Sakemi","year":"1996","journal-title":"Am. J. Nephrol."},{"key":"2022052008350495400_B33","doi-asserted-by":"publisher","first-page":"e0212486","DOI":"10.1371\/journal.pone.0212486","article-title":"Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl\/6 mice","volume":"14","author":"Grant","year":"2019","journal-title":"PloS ONE"},{"key":"2022052008350495400_B34","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00125-021-05483-7","article-title":"AT2R deficiency in mice accelerates podocyte dysfunction in diabetic progeny in a sex-dependent manner","volume":"64","author":"Liao","year":"2021","journal-title":"Diabetologia"},{"key":"2022052008350495400_B35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1042\/CS20210094","article-title":"Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice","volume":"135","author":"Miyata","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"2022052008350495400_B36","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s00125-021-05538-9","article-title":"Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes","volume":"64","author":"Miyata","year":"2021","journal-title":"Diabetologia"},{"key":"2022052008350495400_B37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/excr.1997.3739","article-title":"Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines","volume":"236","author":"Mundel","year":"1997","journal-title":"Exp. Cell. Res."},{"key":"2022052008350495400_B38","doi-asserted-by":"publisher","first-page":"F814","DOI":"10.1152\/ajprenal.00507.2020","article-title":"Angiotensin type 2 receptor activation limits kidney injury during the early phase and induces Treg cells during the late phase of renal ischemia","volume":"320","author":"Ali","year":"2021","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"2022052008350495400_B39","first-page":"227","article-title":"C-C chemokine receptor type 2 mediates glomerular injury and interstitial fibrosis in focal segmental glomerulosclerosis","volume":"35","author":"Wilkening","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"2022052008350495400_B40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2220\/biomedres.31.363","article-title":"The decreases of nephrin and nuclear WT1 in podocytes may cause albuminuria during the experimental sepsis in mice","volume":"31","author":"Kato","year":"2010","journal-title":"Biomed. Res."},{"key":"2022052008350495400_B41","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ki.2014.428","article-title":"Fine-tuning of NFkappaB by glycogen synthase kinase 3beta directs the fate of glomerular podocytes upon injury","volume":"87","author":"Bao","year":"2015","journal-title":"Kidney Int."},{"key":"2022052008350495400_B42","doi-asserted-by":"publisher","first-page":"F1140","DOI":"10.1152\/ajprenal.00216.2009","article-title":"CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo","volume":"298","author":"Marshall","year":"2010","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"2022052008350495400_B43","doi-asserted-by":"publisher","first-page":"20227","DOI":"10.1074\/jbc.RA118.005579","article-title":"The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis","volume":"293","author":"Hu","year":"2018","journal-title":"J. Biol. Chem."},{"key":"2022052008350495400_B44","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/ki.2011.14","article-title":"Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis","volume":"79","author":"Pereira","year":"2011","journal-title":"Kidney Int."},{"key":"2022052008350495400_B45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.kint.2016.06.035","article-title":"Cathepsin L is crucial for the development of early experimental diabetic nephropathy","volume":"90","author":"Garsen","year":"2016","journal-title":"Kidney Int."},{"key":"2022052008350495400_B46","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1172\/JCI32022","article-title":"Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease","volume":"117","author":"Sever","year":"2007","journal-title":"J. Clin. Invest."},{"key":"2022052008350495400_B47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneumeth.2011.06.009","article-title":"Microbore liquid chromatography with UV detection to study the in vivo passage of compound 21, a non-peptidergic AT(2) receptor agonist, to the striatum in rats","volume":"202","author":"Shraim","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"2022052008350495400_B48","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/01.HYP.0000178564.14464.80","article-title":"Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression","volume":"46","author":"Okumura","year":"2005","journal-title":"Hypertension"},{"key":"2022052008350495400_B49","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/HYPERTENSIONAHA.115.05204","article-title":"AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy","volume":"65","author":"Koulis","year":"2015","journal-title":"Hypertension"},{"key":"2022052008350495400_B50","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/HYPERTENSIONAHA.112.196022","article-title":"Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism","volume":"60","author":"Verdonk","year":"2012","journal-title":"Hypertension"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/136\/10\/715\/932997\/cs-2022-0188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/136\/10\/715\/932997\/cs-2022-0188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T08:35:43Z","timestamp":1653035743000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/136\/10\/715\/231257\/Angiotensin-II-type-2-receptor-stimulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,5,27]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20220188","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5]]},"published":{"date-parts":[[2022,5]]}}}